Pharmaceutical Manufacturer Pays $7.9 Million To Resolve Allegations That It Caused The Submission Of Over-the-Counter Drugs To Medicare Part D - Healthcare

Three former prescription drugs were converted by the relevant RLD manufacturers to OTC marketing status in 2020 and 2021.

Related Keywords

,Department Of Justice ,Akorn Operating ,False Claims Act ,Drug Facts Labels ,Cosmetic Act ,Mondaq ,Pharmaceutical Manufacturer Pays 7 9 Million To Resolve Allegations That It Caused The Submission Of Over Counter Drugs Medicare Part D ,Food ,Drugs ,Healthcare ,Life Sciences ,Food And Drugs Law ,